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1034-76 SympatheUc Mechanisms In Whi te  Coat  Hypertension 
Paul A. Smith, L. N. Graham, J. B. Stoker, D. A. Mary, The Leeds Teaching Hospitals, 
Leeds, United Kingdom. 
Background: The development of target organ damage in essential hypertension (EHT) 
adversely affects prognosis, and has been partly, attdbutad to sympathetic hyperactivity. 
tt has also been reported in white coat hypertension (WHT), yet little is known about sym- 
pathetic neural discharge in this condition. We planned to establish whether sympathetic 
hyperactivity occurs in WHT patients in the clinic setting, relative to matched groups with 
EHT and normotension (NT). 
Methods: WHT patients were examined and compared to EHT and NT subjects matched 
for age and body mass index (BMI). We further matched for daytime ambulatory (Arab. 
MBP), and clinic mean blood pressure (MBP), as in Table. WHT was defined as a clinic 
blood pressure of _>140/90 mmHg (a level separating EHT from NT) with a daytime 
ambulatory blood pressure of < 130/80 mmHg. Muscle sympathetic nerve activity 
(MSNA) was measured by microneurography from the peroneal nerve and its mean fre- 
quency was expressed as bursts per 100 cardiac beats (b/100b). 
Results: Data as mean ± SEM for the 3 ~lroups in Table. 
N Age BMI (Kg/ Clinic MBP Daytime Amb.MBP MSNA 
(years) m2) (mmHg) (mmHg) (b/100b) 
NT 12 46 ± 3.9 27 ± 0.8 97 ± 2.2 91 ± 1.5 34 ± 4.4 
WHT 12 46 ± 4.0 29 ± 0.9 115 ± 1.9 92 ± 0.8 47 ± 3.8 
EHT 12 47±3.2 27±0.9 113±1.3 106±1.2 58±2.6 
Using One Way Analysis of Variance, MSNA was significantly (p < 0.05) greater in WHT 
than NT, but was significantly (p < 0.05) less than in EHT. 
Conclusion: It was shown that central sympathetic output was greater in WHT than NT in 
the clinic setting, though it was not as excessive as that seen in EHT. The findings sug- 
gest that WHT is not entirely benign, and that sympathetic hyperactivity may be responsi- 
ble for development of target organ damage in this group of patients. 
the effects of 6 months intensified blood pressure (BP) and (where appropriate) lipid-low- 
ering treatment were investigated. 
Results: TF correlated positively with blood pressure, as well as CHD/CVA risk scores 
(all p<0.001), and negatively with FMD (p<0.001). Plasma levels of TF correlated posi- 
tively with VEGF (Spearman, r=0.640) and vWf (r=0.382), with a negative correlation 
between TF levels and FMD (r=-0.578; all p<0.001). 
Conclusion: In hypertension, the processes of thrombogenesis, endothelial function and 
angiogenesis are abnormal, and correlate with overall cardiovascular isk and with each 
other. Indices of endothelial dysfunction, thrombogenesis and angiogenesis might there- 
fore be useful tools to identity patients at risk. These indices are beneficially affected by 
intensive BP/lipid treatment. 
Controls Hypertensives Hypertensives affer p-value p-value 
[n=48] atBaseline 6monthstreatment (controls vs. (baseline 
[n=76] hypertensives) vs. after 
6 
months) 
Age [years] 62 (8) 64 (8) 0.280 
male:female 41:7 71:5 0.142 
total 5.6 (1.0) 5.8 (1.1) 5.3 (1.3) 0.156 <0.001 
cholesterol 
[mmol/I] 
SBP [mmHg] 134 (13) 167 (15) 144 (13) <0.001 <0.001 
DBP [mmHg] 80 (8) 92 (11) 83 (10) <0.001 <0.001 
FMD [%] 8.6 (2.2) 4.8 (1.3) 7.3 (1.7) <0.001 <0.001 
NID [%] 20.5 (2.3) 19.7 (5.7) 19.9 (6.2) 0.150 0.126 
vWf [IU/dl] 98 (19) 138 (28) 129 (33) <0.001 <0.001 
VEGF [pg/ml] 100(46-200) 400 (210-1450) 270 (180-1050) <0.001 <0.001 
TF [ng/ml] 10 (10-16) 83 (41-210) 65 (25-130) <0.001 <0.001 
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1056-77 Effects of Systemic Hyperinsulinemia on Flow-Mediated 
Dilation of the Brachial Artery in Normal Subjects 
Umberto Camoia. Gall Sullivan, Melissa B. Bryant, Carmine Cardillo, Julio A. Panza, 
Cardiology Branch - NHLB/ - NIH, Bethesda, Maryland. 
Background: Insulin resistance, and the concomitant hyberinsulinemia, are associated 
with premature development of atherosclerosis. However, acute hyperinsutinemia has 
been shown to increase nitric oxide release in the microcirculation, a potentially antiath- 
erosclerotic effect. The actions of insulin on conduit vessels have not been elucidated. 
Therefore, the purpose of this study was to investigate the effects of acute hypednsuline- 
mia on brachial artery endothelial function in healthy subjects. 
Methods: To this end, we studied endothelium-dependent (post-hyperemia flow-medi- 
ated dilation) and -independent (nitroglycerin) vascular responses of the brachial artery 
by high-rasolution ultrasound imaging before and during systemic hyperinsulinemia. 
Eleven healthy subjects (8 men and 3 women; age 47_+10 years) participated in this 
study. 
Results: Brachial artery diameter was similar at baseline and during hyperinsulinemia 
(4.6±0.7 mm and 4.8±0.8 ram, respectively; P=0.38). Similarly, mean reactive hyperemia 
after cuff deflation was unaffected by hyperinsulinemia (545±387% before and 
610~:J17% during insulin infusion; P=0.83). Flow-mediated dilation was significantly 
lower during hyperinsulinemia compared to baseline (3.9±1.3% vs 8±2.4%, respectively; 
P=0.0002). In contrast, the decrease in nitroglycerin-mediated dilation during hyperin- 
sulinemia did not reach statistical significance (9.7±3.4 during insulin infusion vs 
12±4.2% at baseline; P=0.17). 
Conclusions: These findings indicate that, in healthy subjects, acute systemic hyperin- 
sulinemia impairs endothelium-dependent vasodilation of conduit vessels, suggesting a 
potential link between chronic hyperinsulinemic states and the increased cardiovascular 
risk associated with these conditions. 
1056-78 Thrombogenesis, Angiogenesis, and Endothelial 
Function in Hypertension 
Dirk C. Felmeden, Charles G. Spencer, Natali A. Chung, Funmi M. Belgore, Andrew D. 
Blann, Gareth D. Beevers, Gregory Y. Lip, Haemostasis, Thrombosis, and Vascular 
Biology Unit, University Department of Medicine, City Hospital, Birmingham, United 
Kingdom. 
Background: Hypertensive patients are at risk of cardiovascular complications, related to 
endothelial dysfunction, thrombogenesis, and possibly abnormal angiogenesis. These 
processes can be assessed by flow-mediated ilatation (FMD), plasma levels of yon Will- 
ebrand Factor (vWF) [indices of endothelial dysfunction], tissue factor (TF) [index of 
thrambogenesis], and vascular endothelial growth factor (VEGF) [index of angiogenesis]. 
Methods: We studied 76 high-risk hypertensives (71 males; mean age 64) and related 
them to patient's cardiovascular (CHD) and cerabrovascular (CVA) risk, using the 
Framingham equation. These were compared with 48 healthy controls. In hypertensives, 
1056-79 Captopril Increases Endogenous Circulating Plasma 
Bradykinin Concentrations and Improves Endothelial 
Vseod i la tory  Function in the Human Forearm 
Thomas Leoo, JQrg Nussberger, Lars Lind, Bengt yon zur MQhlen, Thomas Kahan, 
Karolinska Institutet Danderyd Hospital, Stockholm, Sweden, Centre Hospitalier 
Universitaire Vaudois, Lausanne, Switzerland. 
Background: The renin-angiotensin system plays a pivotal role in peripheral vascular 
control. Furthermore, bradykinin (BK) has been proposed to be an important endogenous 
factor for nitric oxide release and endothelium dependent vasodilatation. However, 
endogenous plasma concentrations of BK have previously not been well studied. 
Methods: We studied 12 healthy non-smoking subjects (mean age 22 ys, mean blood 
pressure 110/67 mmHg). In the forearm circulation we examined endogenous plasma 
concentrations of BK and angiotensin (Ang) I and II (HPLC followed by RIA), forearm 
blood flow (venous occlusion pletysmography) and endothelium dependent and indepen- 
dent vasodilatation (i.a. metacholine and sodium nitroprusside, respectively). 
Results: In the control situation, arterial and venous BK concentrations and the veno- 
arterial concentration difference were 1.3±0.4, 2.4±0.6 and +1.1±0.5 (P<0.05) pmol/I, 
respectively. Corresponding values for Ang I were 3.7±0.7, 6.6±1.0 and +2.9±0,5 
(P<0.01) pmol/I, and for Ang II 3.8±0.5, 3.0±0.5, and -0.9±0.2 (P<0.01) pmogl, respec- 
tively. Within 60 min of a single 50 mg dose of captopril per os arterial BK increased to 
3.9±1.4 pmoUI (P<0.05), with little influence on venous BK (2.8±0.6 pmol/I). Captopril 
markedly increased arterial Ang I (to 39.9±14.9 pmol/I, P<0.01) and decreased Ang II (to 
0.2±0.1 pmol/I, P<0.01). Endothelial vasodilatory function improved by 16±5% (P<0.05) 
following captopril, with no influence on systemic blood pressure or basal blood flow. 
Conclusion: We demonstrate for the first time a net overflow of endogenous BK in the 
human forearm circulation. A single 50 mg dose of captopril markedly inhibits ACE with 
profound reductions in circulating Ang II concentrations. Captopdl increases arterial BK 
concentrations and augments endothelial vasodilatory function. Thus, improved endothe- 
lial vasodilatory function by ACE-inhibitor therapy may due to the concomitant increased 
availability of endogenous BK. 
:1056-80 Endothelial Vasomotor Function in Humans: Relation to 
the Expression of Endothelial Nitric Oxide Synthase 
Dominik Behrandt. James K. Liao, Scott Kinlay, Mark A. Craager, Andrew P. Selwyn, 
Peter Ganz, Brigham and Women's Hospital, Boston, Massachusetts. 
Background: The bioavailability of nitric oxide is reduced in coronary and peripheral 
srtaries of patients with cardiovascular isk factors and/or atherosclerosis but the molec- 
ular basis for this impairment is incompletely understood. Accordingly, in 17 patients 
undergoing cardiac catheterization for investigation of chest pain, we correlated the 
expression of m-RNA for endothelial nitric oxide synthase (e-NOS) from skin biopsies 
and platalets with coronary and brachial nitric oxide dependent vasomotor responses. 
Methods and Results: The coronary responses were assessed with acetylcholine using 
quantitative angiography end ranged from 7% dilation to -50% constriction (-18±18%, 
mean+ SD, n=10). The brachial responses were assessed by ultrasound during reactive 
hyperemia and ranged from -3% to +11% (5+4%, n=17), e-NOS was measured with 
semiquantitative RT-PCR. Values were normalized to GAPDH and ranged from 0.66 to 
2.35 in the skin and from 0.96 to 2.36 in platelets. The coronary responses to acetylcho- 
line were inversely related to the expression of e-NOB in the skin (r=-0.9, p<0.001). Bra- 
chial flow-mediated dilation revealed a similar but weaker trend of inversely correlating 
with e-NOS (r=-0.34, p=0.19). There was no correlation between platelet e-NOS expres- 
sion and coronary or brachial vasomotor responses. 
Conclusions: In humans, expression of e-NOS mRNA in tissues increases with failure of 
endothelium-dependent vasodilstion. Thus, in humans as in experimental studies, the 
